The FDA approved a new Moderna COVID-19 vaccine aimed at children aged 6 months to 11 years old. The vaccine was previously available under an Emergency Use Authorization (EUA).
The U.S. Food and Drug Administration (FDA) announced a review of clinical trials involving "hostile countries," declaring that projects involving Americans' living cells are paused.
FDA Commissioner Marty Makary confirmed that he will review the safety of the abortion drug mifepristone after a study revealed troubling adverse health outcomes exceeding the risks reported on its label.
The Food and Drug Administration (FDA) has directed BioNTech and Moderna to expand the warning labels on the COVID-19 vaccine to include warnings for heart inflammation.
The U.S. Food and Drug Administration (FDA) has announced plans to remove concentrated ingestible fluoride prescription drug products for children from the market, citing potential health risks.
The U.S. Food and Drug Administration (FDA) announced a sweeping overhaul of how it reviews chemicals already present in the American food supply. The new system will fast-track investigations into several additives long used in consumer goods, including some that have been banned in Europe.
A recent analysis indicates that over 5% of women who took mifepristone for abortion required a second procedure within 45 days, highlighting potential issues with the pill's effectiveness.
